Fidelity Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Sell |
|
|||||
|
2025
Q1 | $701K | Sell |
|
|||||
|
2024
Q4 | $1.14M | Sell |
|
|||||
|
2024
Q3 | $628K | Sell |
|
|||||
|
2024
Q2 | $758K | Buy |
|
|||||
|
2024
Q1 | $833K | Buy |
|
|||||
|
2023
Q4 | $704K | Buy |
|
|||||
|
2023
Q3 | $4.53M | Sell |
|
|||||
|
2023
Q2 | $7.76M | Sell |
|
|||||
|
2023
Q1 | $6.09M | Sell |
|
|||||
|
2022
Q4 | $12.2M | Sell |
|
|||||
|
2022
Q3 | $18M | Sell |
|
|||||
|
2022
Q2 | $17.3M | Buy |
|
|||||
|
2022
Q1 | $20.9M | Sell |
|
|||||
|
2021
Q4 | $21.5M | Sell |
|
|||||
|
2021
Q3 | $28.5M | Sell |
|
|||||
|
2021
Q2 | $29.7M | Buy |
|
|||||
|
2021
Q1 | $37.8M | Buy |
|
|||||
|
2020
Q4 | $1.33M | Hold |
|
|||||
|
2020
Q3 | $529K | Hold |
|
|||||
|
2020
Q2 | $334K | Sell |
|
|||||
|
2020
Q1 | $215K | Buy |
|
|||||
|
2019
Q4 | $389K | Sell |
|
|||||
|
2019
Q3 | $223K | Sell |
|
|||||
|
2019
Q2 | $3M | Buy |
|
|||||
|
2019
Q1 | $6.41M | Sell |
|
|||||
|
2018
Q4 | $15.3M | Sell |
|
|||||
|
2018
Q3 | $42M | Sell |
|
|||||
|
2018
Q2 | $67M | Buy |
|
|||||
|
2018
Q1 | $44.8M | Sell |
|
|||||
|
2017
Q4 | $65.8M | Buy |
|
|||||
|
2017
Q3 | $55.6M | Buy |
|
|||||
|
2017
Q2 | $51.4M | Buy |
|
|||||
|
2017
Q1 | $49.3M | Buy |
|
|||||
|
2016
Q4 | $12.7M | Sell |
|
|||||
|
2016
Q3 | $68.1M | Sell |
|
|||||
|
2016
Q2 | $51.5M | Sell |
|
|||||
|
2016
Q1 | $72.1M | Hold |
|
|||||
|
2015
Q4 | $102M | Buy |
|